Intrinsic Antiviral Activity of Optineurin Prevents Hyperproliferation of a Primary Herpes Simplex Virus Type 2

Chandrashekhar D Patil1, Rahul Suryawanshi1, Joshua Ames1,2

  • 1Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL.

Insights

Optineurin (OPTN) restricts herpes simplex virus type 2 (HSV-2) genital infections by enhancing autophagy and CCL5 induction. OPTN deficiency exacerbates disease, highlighting its role in intrinsic host defense against HSV-2.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Limited understanding of host cell mechanisms controlling herpes simplex virus type 2 (HSV-2) genital infections.
  • Optineurin (OPTN) has been reported to play a proviral role in other viral infections.

Purpose of the Study:

  • To investigate the role of optineurin (OPTN) in restricting primary HSV-2 genital infections.
  • To elucidate the intrinsic host cell mechanisms involving OPTN during HSV-2 infection.

Main Methods:

  • In vitro and in vivo studies using cell cultures and OPTN knockout (OPTN-/-) mice.
  • Analysis of viral production, autophagy response, CCL5 induction, and T cell frequencies.
  • Examination of human transcriptomic data.

Main Results:

  • OPTN deficiency led to enhanced HSV-2 production in vitro.
  • OPTN knockout mice exhibited exacerbated genital disease and altered T cell responses.
  • OPTN deficiency impaired autophagy and reduced CCL5 induction.
  • Human data confirmed a positive correlation between CCL5 and OPTN expression in HSV-2 infection.

Conclusions:

  • Optineurin (OPTN) acts as a crucial intrinsic host factor restricting HSV-2 replication and spread.
  • The OPTN/CCL5 pathway is identified as a novel mechanism limiting hyperproliferative HSV-2 infection.
  • Findings suggest a potential host defense strategy against herpesviruses.